• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-TPD52L2

TPD52L2 Polyclonal Antibody for IF, IHC, IP, WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IP, IHC, IF, ELISA

Conjugaison

Non conjugué

N° de cat : 11795-1-AP

Synonymes

D54, hD54, TPD52L2, TPD54, tumor protein D52 like 2, Tumor protein D54



Applications testées

Résultats positifs en WBcellules HEK-293, cellules MCF-7, tissu cérébral de rat, tissu cérébral de souris
Résultats positifs en IPcellules HEK-293
Résultats positifs en IHCtissu de cancer du sein humain,
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IFcellules HepG2,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

11795-1-AP cible TPD52L2 dans les applications de WB, IP, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène TPD52L2 Protéine recombinante Ag2364
Nom complet tumor protein D52-like 2
Masse moléculaire calculée 206 aa, 22 kDa
Poids moléculaire observé 25-30 kDa
Numéro d’acquisition GenBankBC006804
Symbole du gène TPD52L2
Identification du gène (NCBI) 7165
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Tumor protein D52-like proteins (TPD52) are small coiled-coil motif bearing proteins that were first identified in breast carcinoma. Three human TPD52 members had been identified, named hD52 (TPD52), hD53 (TPD52L1), and hD54 (TPD52L2). The most important characteristic of the protein family is a highly conserved coiled-coil motif that is required for homo- and heteromeric interaction with other TPD52-like proteins. TPD52 and related proteins have been implicated in cell proliferation, apoptosis, and vesicle trafficking. TPD52L2 has five isoforms produced by alternative splicing, and its multiple sites have been identified to be phosphorylated. Interaction of TPD52L2 with MAL2, a novel member of the MAL proteolipid family, may be required for the role of TPD52L2 in vesicle transport.

Protocole

Product Specific Protocols
WB protocol for TPD52L2 antibody 11795-1-APDownload protocol
IHC protocol for TPD52L2 antibody 11795-1-APDownload protocol
IF protocol for TPD52L2 antibody 11795-1-APDownload protocol
IP protocol for TPD52L2 antibody 11795-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Carcinogenesis

TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.

Authors - Zhou Qiang
  • KD Validated
humanWB

Cell Biosci

Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance.

Authors - Yuzo Abe
humanIF

J Biol Chem

Tumor protein D54 binds intracellular nanovesicles via an extended amphipathic region.

Authors - Antoine Reynaud
human,mouseWB,IHC,IP

Int J Oncol

Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells.

Authors - Kosuke Kato
mouseWB,IHC

Biomed Res Int

Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of Chondrocytes.

Authors - Chihiro Ito
humanWB

Neoplasma

Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway.

Authors - Z Wang
  • KD Validated

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Jerome (Verified Customer) (01-05-2020)

Puncta in the cytoplasm

  • Applications: Immunofluorescence,
  • Primary Antibody Dilution: 1:100
  • Cell Tissue Type: HeLa cells
TPD52L2 Antibody Immunofluorescence, validation (1:100 dilution) in HeLa cells (Cat no:11795-1-AP)